105 related articles for article (PubMed ID: 1550082)
1. Analysis of treatment failure in acute nonlymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group study.
Ryan DH; Kopecky KJ; Head D; Grever MR; Shiaer SM; Lipschitz DA; Hynes HE; Vial RH; Veith RW; Gumbart CH
Am J Clin Oncol; 1992 Feb; 15(1):69-75. PubMed ID: 1550082
[TBL] [Abstract][Full Text] [Related]
2. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute myelogenous leukemia in patients over 50 years of age with V-TAD: a Southwest Oncology Group study.
Bigelow CL; Kopecky K; Files JC; Head D; Lipschitz DA; Grever M; Appelbaum FR
Am J Hematol; 1995 Apr; 48(4):228-32. PubMed ID: 7717369
[TBL] [Abstract][Full Text] [Related]
4. A randomized study of the efficacy of postconsolidation therapy in adult acute nonlymphocytic leukemia: a report of the Italian Cooperative Group GIMEMA.
Mandelli F; Vegna ML; Avvisati G; Amadori S; Spadea A; Cacciola E; Cantore N; De Laurenzi A; De Rosa C; Fioritoni G
Ann Hematol; 1992 Apr; 64(4):166-72. PubMed ID: 1581404
[TBL] [Abstract][Full Text] [Related]
5. The influence of induction chemotherapy dose and dose intensity on the duration of remission in acute myeloid leukemia. Australian Leukemia Study Group.
Bishop JF; Matthews JP; Young G; Szer J; Joshua DE; Dodds A; Laidlaw CR; Cobcroft R; Herrman R; Ma D
Leuk Lymphoma; 1994 Sep; 15(1-2):79-84. PubMed ID: 7858505
[TBL] [Abstract][Full Text] [Related]
6. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
[TBL] [Abstract][Full Text] [Related]
7. Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group.
Bishop JF; Lowenthal RM; Joshua D; Matthews JP; Todd D; Cobcroft R; Whiteside MG; Kronenberg H; Ma D; Dodds A
Blood; 1990 Jan; 75(1):27-32. PubMed ID: 2403818
[TBL] [Abstract][Full Text] [Related]
8. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
Hansen OP; Pedersen-Bjergaard J; Ellegaard J; Brincker H; Boesen AM; Christensen BE; Drivsholm A; Hippe E; Jans H; Jensen KB
Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
[TBL] [Abstract][Full Text] [Related]
9. High-dose cytosine arabinoside as consolidation chemotherapy for acute nonlymphocytic leukemia in remission.
Urabe A; Mizoguchi H; Hoshino S; Nomura T; Dan K; Toyama K; Kimura M; Ogawa T; Yamaguchi H; Mutoh Y
Int J Hematol; 1991 Feb; 54(1):75-7. PubMed ID: 1954354
[TBL] [Abstract][Full Text] [Related]
10. Induction failures in childhood acute nonlymphocytic leukemia: etoposide/5-azacytidine for cases refractory to daunorubicin/cytarabine.
Kalwinsky DK; Dahl GV; Mirro J; Jackson CW; Look AT
Med Pediatr Oncol; 1986; 14(5):245-50. PubMed ID: 2431255
[TBL] [Abstract][Full Text] [Related]
11. High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study Group.
Lazarus HM; Vogler WR; Burns CP; Winton EF
Cancer; 1989 Mar; 63(6):1055-9. PubMed ID: 2917307
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M
Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
[TBL] [Abstract][Full Text] [Related]
13. [The curative treatment of adult acute nonlymphocytic leukemia].
Uzuka Y; Saito Y
Rinsho Ketsueki; 1989 Aug; 30(8):1163-6. PubMed ID: 2601025
[TBL] [Abstract][Full Text] [Related]
14. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI
Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone and cytosine arabinoside in previously untreated adult patients with acute non-lymphocytic leukemia.
Osman I; Akin U; Ismet A; Meral B; Hamdi A; Haluk K
Haematologia (Budap); 1996; 27(2):93-7. PubMed ID: 14651226
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
Löwenberg B; Suciu S; Archimbaud E; Haak H; Stryckmans P; de Cataldo R; Dekker AW; Berneman ZN; Thyss A; van der Lelie J; Sonneveld P; Visani G; Fillet G; Hayat M; Hagemeijer A; Solbu G; Zittoun R
J Clin Oncol; 1998 Mar; 16(3):872-81. PubMed ID: 9508168
[TBL] [Abstract][Full Text] [Related]
17. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
[TBL] [Abstract][Full Text] [Related]
18. The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia.
Woods WG; Ruymann FB; Lampkin BC; Buckley JD; Bernstein ID; Srivastava AK; Smithson WA; Benjamin DR; Feig SA; Kim TH
Cancer; 1990 Sep; 66(6):1106-13. PubMed ID: 2205352
[TBL] [Abstract][Full Text] [Related]
19. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
[TBL] [Abstract][Full Text] [Related]
20. A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study.
Steuber CP; Civin C; Krischer J; Culbert S; Ragab A; Ruymann FB; Ravindranath Y; Leventhal B; Wilkinson R; Vietti TJ
J Clin Oncol; 1991 Feb; 9(2):247-58. PubMed ID: 1988573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]